Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pain ; 16(10): 1357-67, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22467279

ABSTRACT

BACKGROUND: Peripheral nerve injury is associated with a spinal microglial response that has been correlated with the development of behaviours reflective of neuropathic pain. METHODS: To examine whether this phenomenon is generalizable to neuropathic pain of non-traumatic aetiology, this study investigated the association between spinal microgliosis and behavioural measures of neuropathic hypersensitivity and pain-related anxiety behaviour in four distinct rat models of peripheral neuropathic pain. These were traumatic neuropathy [L5 spinal nerve transection (SNT)], HIV-related neuropathies (either treatment with the antiretroviral drug Zalcitabine (ddC) or combination of perineural exposure to the HIV-gp120 protein and ddC treatment) and varicella zoster virus (VZV) infection. RESULTS AND CONCLUSION: Persistent mechanical hypersensitivity developed in all 'neuropathic' rats. However, spinal microgliosis, as measured by increased CD11b/c immunohistochemical staining and increased numbers of cells expressing CD11b measured by flow cytometry, was evident in the SNT and to a lesser extent in the HIV neuropathy models but not the VZV model. These results suggest that behavioural hypersensitivity and thigmotaxis can only be linked to a microglial response in certain models of neuropathy.


Subject(s)
Behavior, Animal , Gliosis/pathology , Microglia/pathology , Peripheral Nervous System Diseases/pathology , Spinal Cord/pathology , Animals , Anti-HIV Agents/adverse effects , Disease Models, Animal , Flow Cytometry , HIV Envelope Protein gp120/adverse effects , HIV Infections/complications , HIV Infections/pathology , Herpes Zoster/complications , Herpes Zoster/pathology , Herpesvirus 3, Human , Hyperalgesia/pathology , Immunohistochemistry , Male , Peripheral Nerve Injuries/complications , Peripheral Nerve Injuries/pathology , Peripheral Nervous System Diseases/etiology , Rats , Rats, Wistar , Spinal Nerves/injuries , Zalcitabine/adverse effects
2.
Anaesthesia ; 65(1): 27-35, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19889110

ABSTRACT

Reduced HLA-DR expression on monocytes has been suggested as a predictive marker of immunosuppression following very high risk surgery, but there are few reports in lower risk surgery. In 32 patients undergoing low to intermediate risk surgery, blood samples were analysed by flow cytometry for HLA-DR expression and numbers in both CD14(high) and CD14(low)CD16+ monocyte subsets. The numbers of CD14(high) monocytes increased at 24 h (mean (SD), 5.0 (2.2) vs 7.6 (3.9) x 10(5) cells.ml(-1); p < 0.01) while CD14(low)CD16+ monocytes decreased (0.68 (0.36) vs 0.44 (0.36) x 10(5) cells.ml(-1); p < 0.01). HLA-DR expression was significantly reduced in both subsets by 24 h (mean (SD) fluorescent intensity 440 (310) vs 160 (130) for CD14(high) and 1000 (410) vs 560 (380) for CD14(low)CD16+ subsets; p < 0.01). This reduction of monocyte HLA-DR expression 24 h following lower risk surgery raises questions about the purported clinical utility of this biomarker as an early predictor of postoperative complications. Our results also suggest that surgery induces significant trafficking (i.e. mobilisation, margination and extravasation) of monocyte subsets, and that monocyte HLA-DR depression is the result of a down-regulatory phenomenon (decreased protein expression on each cell) rather than the differential trafficking of monocyte subsets.


Subject(s)
HLA-DR Antigens/blood , Monocytes/immunology , Surgical Procedures, Operative , Abdomen/surgery , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement , Bariatric Surgery , Female , Flow Cytometry/methods , Humans , Immune Tolerance/immunology , Leukocyte Count , Male , Middle Aged , Postoperative Period , Prospective Studies
3.
J Neurosci Methods ; 164(2): 207-17, 2007 Aug 30.
Article in English | MEDLINE | ID: mdl-17553569

ABSTRACT

Microgliosis is implicated in the pathophysiology of several neurological disorders, including neuropathic pain. Consequently, perturbation of microgliosis is a mechanistic and drug development target in neuropathic pain, which highlights the requirement for specific, sensitive and reproducible methods of microgliosis measurement. In this study, we used the spinal microgliosis associated with L5 spinal nerve transection and minocycline-induced attenuation thereof to: (1) evaluate novel software based semi-quantitative image analysis paradigms for the assessment of immunohistochemical images. Microgliosis was revealed by immunoreactivity to OX42. Several image analysis paradigms were assessed and compared to a previously validated subjective categorical rating scale. This comparison revealed that grey scale measurement of the proportion of a defined area of spinal cord occupied by OX42 immunoreactive cells is a robust image analysis paradigm. (2) Develop and validate a flow cytometric approach for quantification of spinal microgliosis. The flow cytometric technique reliably quantified microgliosis in spinal cord cell suspensions, using OX42 and ED9 immunoreactivity to identify microglia. The results suggest that image analysis of immunohistochemical revelation of microgliosis reliably detects the spinal microgliosis in response to peripheral nerve injury and pharmacological attenuation thereof. In addition, flow cytometry provides an alternative approach for quantitative analysis of spinal microgliosis elicited by nerve injury.


Subject(s)
Diagnostic Imaging/methods , Flow Cytometry/methods , Immunohistochemistry/methods , Microglia/pathology , Peripheral Nervous System Diseases/pathology , Spinal Cord/pathology , Animals , Anti-Bacterial Agents/therapeutic use , Antigens, Differentiation/metabolism , CD11b Antigen/metabolism , Functional Laterality , Male , Microglia/drug effects , Microglia/metabolism , Minocycline/therapeutic use , Peripheral Nervous System Diseases/drug therapy , Rats , Rats, Wistar , Reproducibility of Results , Software , Spinal Cord/drug effects , Statistics, Nonparametric
4.
Parasite Immunol ; 18(4): 165-72, 1996 Apr.
Article in English | MEDLINE | ID: mdl-9223171

ABSTRACT

During the course of chronic malaria infection antigenic variants of a parasite antigen are expressed and exposed on the surface of infected erythrocyte membranes. There also exists a number of apparently invariant single gene copy blood-stage antigens, exposed or non-exposed, which have been shown to afford immunity under experimental conditions. To determine why the host, presented with invariant 'protective' antigens, is unable to control infections effectively, immunity to a representative single gene copy antigen, the merozoite surface protein 1 (MSP1) was investigated in Plasmodium chabaudi chabaudi AS, a murine model of chronic malaria. Immunization with monoclonal antibody affinity purified native MSP1 resulted in enhanced control of parasitaemia on challenge, irrespective of the parasite inoculum size; challenge with a single parasite, however, suggested that expansion of resistant parasite subpopulations was not occurring. Challenge of mice immunized with recombinant fusion proteins encoding N- or C-terminal regions of the P.c. chabaudi AS MSP1 produced inconsistent effects, often parasitaemias were indistinguishable from controls despite significant anti-MSP1 antibody responses. The not unlikely contamination of MSP1 native preparations with erythrocyte (E) components was considered. Immunization with a mixture of the MSP1 C-terminus recombinant polypeptide and a Triton X-100 solubilized lysate of normal E resulted in enhanced control of parasitaemia, however, no effect was seen after administration of either component on its own. Co-immunization of E with the N-terminus polypeptide reversed the inhibition seen, on this occasion with this construct alone.


Subject(s)
Antigens, Protozoan/genetics , Antigens, Surface/genetics , Genes, Protozoan , Malaria/immunology , Plasmodium chabaudi/genetics , Plasmodium chabaudi/immunology , Animals , Antigenic Variation , Erythrocytes/immunology , Erythrocytes/parasitology , Immunization , Malaria/parasitology , Male , Merozoite Surface Protein 1 , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred CBA , Parasitemia/immunology , Plasmodium chabaudi/growth & development , Protein Precursors/genetics , Protein Precursors/immunology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Recombinant Proteins/immunology , Time Factors
5.
Mol Biochem Parasitol ; 72(1-2): 111-9, 1995 Jun.
Article in English | MEDLINE | ID: mdl-8538682

ABSTRACT

Processing of the Plasmodium merozoite surface protein 1 (MSP-1) has been described for parasites maintained under in vitro conditions. We have now demonstrated, using CBA/Ca mice infected with Plasmodium chabaudi chabaudi AS, that MSP-1 processing also occurs in vivo. The major proteolytic cleavage sites and a processing scheme were deduced from N-terminal amino-acid sequences of the MSP-1 breakdown products. Comparison of MSP-1 processing in P. falciparum and P.c. chabaudi indicates a degree of conservation and in two cases the position of protease cleavage appears identical. Significant amounts of MSP-1 polypeptides are found in plasma during schizogony. Various aspects of MSP-1 processing including immunological and physiological reactions in the host during the critical period of schizogony can now be examined in vivo.


Subject(s)
Antigens, Protozoan/metabolism , Plasmodium chabaudi/metabolism , Protein Precursors/metabolism , Protozoan Proteins/metabolism , Amino Acid Sequence , Animals , Endopeptidases/metabolism , Malaria/parasitology , Merozoite Surface Protein 1 , Mice , Molecular Sequence Data , Parasitemia/parasitology , Plasmodium chabaudi/growth & development , Plasmodium chabaudi/immunology , Plasmodium chabaudi/isolation & purification , Plasmodium falciparum/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...